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http:WHAT THIS PAPER ADDS
Acceptable limb salvage rates underlie wide use of endovascular therapy (EVT) for patients with critical limb
ischemia secondary to isolated infrapopliteal lesions; however, delayed wound healing after revascularization
remains a challenge. This study, involving 871 consecutive critically ischemic limbs, examines factors associated
with delayed wound healing after EVT. Risk stratiﬁcation based on these predictors allows wound healing rate
estimation.Objectives: Acceptable limb salvage rates underlie the widespread use of endovascular therapy (EVT) for patients
with critical limb ischemia (CLI) secondary to isolated infrapopliteal lesions; however, post-EVT delayed wound
healing remains a challenge. Predictors of delayed wound healing and their use in risk stratiﬁcation of EVT in
patients with CLI due to isolated infrapopliteal lesions are explored.
Methods: This was a retrospective multicenter study. 871 consecutive critically ischemic limbs were studied.
There was tissue loss in 734 patients (age: 71  10 years old; 71% male) who had undergone EVT between April
2004 and December 2012. The wound healing rate after EVT was estimated by the KaplaneMeier method. The
association between baseline characteristics and delayed wound healing was assessed by the Cox proportional
hazard model.
Results: Diabetes mellitus and regular dialysis were present in 75% (553/734) and 64% (476/734) of patients,
respectively; 67% of limbs (585/871) had Rutherford class 5 CLI; 8% (67/871) of wounds were located in the heel
only; 25% (219/871) of limbs had Rutherford 6 (involving not only the heel); and 42% (354/871) of wounds were
complicated by infection. The rate of freedom from major amputation at 1 year reached 88%, whereas the wound
healing rate was 67%. Median time to wound healing was 146 days. By multivariate analysis, non-ambulatory
status (hazard ratio [HR], 1.58; 95% conﬁdence interval [CI] 1.31e1.91) serum albumin <3 g/dL (HR 1.42; 95% CI
1.08e1.86), Rutherford 6 (not only heel) (HR 1.68; 95% CI 1.33e2.14), wound infection (HR 1.24; 95% CI 1.03e
1.50), EVT not based on angiosome concept (HR 1.28; 95% CI 1.06e1.55), and below the ankle (BTA) 0 vessel
runoff after EVT (HR 1.45; 95% CI 1.14e1.86) were independent predictors of delayed wound healing.rresponding author. T. Shiraki, Kansai Rosai Hospital Cardiovascular Center, 3-1-69 Inabasou, Amagasaki, Hyogo 660-8511, Japan.
il address: shiraki.tatsuya@gail.com (T. Shiraki).
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566Conclusions: Non-ambulatory status, low albumin level, Rutherford 6 (not only heel), wound infection, indirect
intervention, and poor BTA runoff were independent predictors for delayed wound healing after EVT in patients
with CLI secondary to infrapopliteal lesions, and their use in risk stratiﬁcation allows estimation of the wound
healing rate.
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stratiﬁcationINTRODUCTION
Critical limb ischemia (CLI), the most severe clinical mani-
festation of peripheral artery disease (PAD), is characterized
by ischemic rest pain or the presence of ischemic tissue loss
with or without gangrene.1 According to the Trans-Atlantic
Inter-Society Consensus (TASC) II, the primary objectives
of CLI treatment are to relieve ischemic pain, heal ischemic
ulcers, prevent limb loss, improve patient function and
quality of life (QOL), and prolong survival.1 When techni-
cally possible, revascularization, including bypass surgery
(BSX) and endovascular therapy (EVT), are considered
optimal treatments for patients with CLI in the latest PAD
guidelines.1e3 Furthermore, EVT has become commonplace
as the revascularization strategy for infrapopliteal lesions in
patients with CLI because of comparable limb salvage rates
to BSX and its less invasive nature.4 In the management of
CLI with tissue loss, delayed wound healing not only lowers
QOL but also increases medical costs, even if limb loss is
successfully prevented.5,6
For BSX, reports have documented 1 year wound healing
rates in the 74e85% range, and median wound healing time
of 173e186 days post procedure7,8 with regular dialysis,
diabetes mellitus, low albumin level, non-ambulatory sta-
tus, and Rutherford category 6 as predictors of delayed
wound healing.9
For EVT, the 1 year wound healing rate and median
healing time were 54e86% and 97e145 days, respec-
tively.10e12 Factors associated with delayed wound healing
after EVT were diabetes mellitus, wound infection, below
the ankle (BTA) runoff, and body mass index
(BMI) < 18.5 kg/m2.11,12
Previous studies have been more limited in the outcomes
examined and have not reported the risk stratiﬁcation for
wound healing,7e12 therefore in this study 871 limbs with
ischemic tissue loss due to infrapopliteal lesions were
analyzed to assess and risk stratify the wound healing rate
and predictors after EVT.MATERIALS AND METHODS
Study design
This study is a sub-analysis of J-BEAT (Japanese BElow the
knee Artery Treatment registry: No. UMIN 000004917), a
non-randomized multicenter study approved by the insti-
tutional review boards at all 14 participating cardiovascular
and vascular institutions in Japan. The study protocol was
developed in accordance with the Declaration of Helsinkiand approved by the ethics committee of each participating
hospital.
Participants
During the study period, 1316 limbs from 1078 CLI patients
presenting with isolated infrapopliteal lesions were treated
with plain balloon angioplasty. Patients with CLI without
tissue loss (n ¼ 321 limbs) were excluded from this analysis.
Other exclusion criteria were (a) above ankle ischemic ulcer
(n ¼ 17 limbs); (b) failed EVT, deﬁned as no below knee
runoff vessel after EVT (n ¼ 81 limbs); and (c) data missing
on wound condition (n ¼ 26 limbs). Finally, 871 limbs in 734
consecutive CLI patients who had undergone EVT for de
novo infrapopliteal lesions were enrolled between April
2004 and December 2012.
The database excluded patients who were considered
poor candidates for revascularization due to severe
comorbidities and impairment at the functional (bedridden
without intractable rest pain) and/or cognitive (dementia
not requiring institutionalization) levels, or who refused
revascularization. Although intervention was not attempted
in patients with functionally unsalvageable limbs, non-
ambulatory patients without cognitive problems were
treated by angioplasty for limb salvage taking into consid-
eration the patient’s preference, family cooperation, and
lack of control of rest pain with analgesics.
Intervention
Indication and strategy for EVT were decided by consensus
among vascular surgeons, interventional cardiologists, and
interventional radiologists, depending on general condition,
comorbidity and lower limb severity. Patients with >2 year
life expectancy, and CLI patients with Rutherford 6 with
good autogenous vein (diameter > 3 cm) were commonly
selected for primary surgical bypass therapy.
All EVT procedures were performed under local anes-
thesia. Generally, a 3 or 4Fr sheath was used via an ante-
grade approach from the ipsilateral common femoral artery.
After inserting the sheath, unfractionated heparin (5000
units) was routinely administered into the artery. A 0.014
inch guidewire was advanced into the culprit lesion and it
was dilated using an optimally sized balloon catheter at the
operator’s discretion. Basically, the diameter of the distal
part of the healthy vessel was used as reference to decide
balloon size. Stent, drug coated balloon, and atherectomy
devices were not approved for use in infrapopliteal inter-
vention in Japan.
Table 1. Rutherford category of critical limb ischemia.
Category Clinical description
Rutherford 5 Minor tissue loss: non healing ulcer, focal
gangrene not exceeding foot digit
Rutherford 6 Major tissue loss: extending above
transmetatarsal level, functional foot no longer
salvageable
only heel Ulcer/gangrene located at heel only
not only heel Ulcer/gangrene located at mid-foot; toe and
heel; mid-foot and heel
Mid-foot means extending above transmetatarsal level.
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non-healing ulceration/gangrene was conﬁrmed and the
angiosome based favorable target lesion was assessed by
digital subtraction angiography. Angiosome oriented arterial
recanalization was ﬁrst attempted and if an angiosome
based straight line was achieved other lesions with residual
stenosis were not treated. However, if treatment of the
angiosome based target lesions was unsuccessful, a non-
angiosome oriented lesion was treated.
Antiplatelet therapy with aspirin (100 mg daily) and clo-
pidogrel (75 mg daily) or cilostazol (100 mg twice daily) was
started at least 1 week before EVT and continued for life.Follow up protocol
All patients were followed up at 1 week, 1, 3, and 6 months
after revascularization, and thereafter every 3 months.
Overall and limb status, ankleebrachial index (ABI), and skin
perfusion pressure (SPP) were routinely checked at follow
up. SPP (Sensilase PAD 3000, Väsamed, Eden Prairie, MN,
USA) was regularly measured at the dorsal and plantar sides
of the foot. If a patient did not return to the hospital, limb
status and patient’s general health were checked via phone
interview (the last one applied in approximately 20% of
cases).Wound management
Wound status evaluation and wound care management
were decided by plastic surgeons who evaluated and
managed the ulcer using the TIME concept during follow
up. TIME is an acronym for the following: T ¼ tissue;
I ¼ infection or inﬂammation; M ¼ moisture imbalance;
E ¼ edge of wound (non-advancing or undermined).
Severity of wounds, especially of those infected, was care-
fully assessed by plastic surgeons who decided on indication
for antibiotic therapy and amputation timing. Ulcer status
and time to complete healing were recorded.
Repeat intervention was performed when delayed heal-
ing, worsening of the wound, or exacerbation of rest pain
was recognized. A SPP <40 mmHg was deﬁned as evidence
of ischemia requiring re-intervention.Outcome measures and variables
The outcome measures of this study were major amputa-
tion rate, complete wound healing rate, and median healing
time after EVT. Factors associated with delayed wound
healing after EVT were examined by multivariate analysis.
Clinical variables found to inﬂuence wound healing in pre-
vious studies9,11 were inserted into the multivariate
analysis.
The pre-procedural variables considered were age, sex,
BMI, ambulatory status, Rutherford classiﬁcation, presence
of infection, diabetes mellitus, hypertension, dyslipidemia,
regular hemodialysis, and serum albumin level as a nutri-
tional marker.
The procedural variables considered in relation to
outcome measures in this study were angiosome based EVT,the number of patent below knee and below ankle arteries
after the procedure.Deﬁnitions
Ischemic tissue loss was deﬁned in accordance with TASC as
tissue loss associated with ankle pressure <70 mmHg or a
toe pressure <50 mmHg.1 When these measurements
could not be obtained, SPP was measured. An SPP
<40 mmHg was deﬁned as indicating ischemic tissue loss.13
Major amputation means above ankle amputation. Com-
plete wound healing was deﬁned as achievement of com-
plete epithelialization of all wounds without death or major
amputation. Healing time was deﬁned as time elapsed from
initial EVT to complete epithelialization. Patients who died
before wound healing was achieved were counted under
delayed wound healing, with date of death as the cutoff
date. In patients who underwent major amputation, the
healing time was considered to be inﬁnite. Delayed wound
healing was deﬁned as healing that took over 1 year, death
before complete healing, or major amputation.
Wounds were classiﬁed according to the Rutherford
classiﬁcation. Rutherford 5 is minor tissue loss: non-healing
ulcer, focal gangrene with diffuse pedal ischemia.14 Ruth-
erford 6 is major tissue loss: extending above trans-
metatarsal level of functional foot, no longer limb
salvageable or located at heel.14 In this study, Rutherford 6
was assigned to “not only heel” and “only heel” (Table 1).
Isolated infrapopliteal artery disease was deﬁned as
ischemia secondary to tibial lesions without any signiﬁcant
popliteal, femoral, iliac, and aortic lesions. Non-ambulatory
status was deﬁned as wheelchair bound or bedridden. The
diagnosis of diabetes was based on World Health Organi-
zation criteria or on having been treated with insulin and/or
an oral hypoglycemic agent. Hypertension was diagnosed as
systolic blood pressure 130 mmHg or diastolic blood
pressure 80 mmHg or having been treated for hyperten-
sion. Dyslipidemia was deﬁned as serum low density lipo-
protein (LDL) cholesterol  100 mg/dL or high density
lipoprotein (HDL) cholesterol < 40 mg/dL or
triglycerides  150 mg/dL, or having been treated for
dyslipidemia.
Successful EVT was deﬁned as < 25% residual stenosis
without any ﬂow reduction in target lesions on the ﬁnal
angiogram. Unsuccessful EVT was deﬁned as failure to cross
the lesion with guidewire or as ongoing ﬂow reduction after
Table 2. Baseline characteristics.
Mean  SD (n) n (%)
Patient characteristics (n ¼ 734)
Age, years 70.9  10.4
Age  80 years 155 (21)
Male 524 (71)
BMI 21.6  3.4
BMI < 18.5 kg/m2 135 (18)
Non-ambulatory status 329 (45)
Serum albumin 3.5  0.6
Serum albumin <3.0 g/dL 165 (22)
Risk factors
Hypertension 532 (72)
Dyslipidemia 287 (39)
Diabetes mellitus 553 (75)
Hemodialysis 476 (64)
Lower limb characteristics (n ¼ 871)
Rutherford classiﬁcation
Rutherford 5 585 (67)
Rutherford 6 286 (33)
Only heel 67 (8)
Not only heel 219 (25)
Infection 364 (42)
EVT procedure
Direct intervention 546 (62)
Number of patent BTK runoff vessels after EVT
3 189 (22)
2 312 (36)
1 370 (42)
Number of patent BTA runoff vessels after EVT
2 281 (32)
1 373 (43)
0 217 (25)
BMI ¼ body mass index; EVT ¼ endovascular therapy;
BTK ¼ below the knee; BTA ¼ below the ankle.
568 T. Shiraki et al.balloon angioplasty. At the time of ﬁnal angiography, EVT
success or failure was judged by the chief operator. Direct
EVT referred to successful revascularization based on the
angiosome concept, whereas indirect EVT was that achieved
not based on this concept.15e17 Repeat EVT was deﬁned as
target limb EVT. The number of below knee runoff vessels
was 0e3 based on anterior tibial, peroneal, and posterior
tibial arteries. The number of below ankle runoff vessels
ranged from 0 to 2 based on the dorsal pedis and lateral
plantar arteries.Statistical analysis
Data are expressed as mean and standard deviation for
continuous variables or as percentage for dichotomous
variables, unless otherwise mentioned. The survival rate
and rates for major amputation and wound healing were
assessed with the KaplaneMeier method. Univariate and
multivariate Cox proportional hazards regression models
were used to investigate the un-adjusted and adjusted as-
sociation of pre-procedural and procedural variables with
complete wound healing, respectively. The developed risk
stratiﬁcation was identiﬁed from the variables indepen-
dently associated with delayed wound healing in this study.
The sensitivity and speciﬁcity for major limb amputationwere calculated by time dependent receiver operating
characteristic curve analyses.18 Hazard ratios (HRs) and 95%
conﬁdence intervals (CIs) are reported. Variables with sta-
tistical signiﬁcance in the multivariate model were deter-
mined as independent risk factors for outcome. A p
value < .05 was considered signiﬁcant. Statistical analyses
were performed with SPSS version 15.0J (SPSS Inc., Chicago,
IL, USA).
RESULTS
As shown in Table 2, the mean age was 71  10 years, and
21% (155/734) of study participants were octogenarians;
524 patients (71%) were male. The average BMI was
21.6  3.4, and the prevalence of emaciation (BMI < 18.5)
was 18% (135/734). The mean serum albumin level was
3.5  0.6 g/dL, with 22% (165/734) of patients having low
albumin levels (<3 g/dL). Notable comorbidities included
diabetes mellitus (75%; 553/734), followed by regular dial-
ysis dependence (64%; 476/734). Regarding limb condition,
the mean SPP before and up to 48 hours after EVT was
31  17 mmHg and 49  22 mmHg, respectively (data not
shown). The fact that over 60% of the patients were on
dialysis, which was associated with calciﬁcation, may ac-
count for the falsely high ABI. Rutherford 5 was observed in
67% (585/871) of limbs, and Rutherford 6 in 286 limbs
(33%). Among Rutherford 6 limbs, the wound was located in
only the heel in 8% (67/871), and also elsewhere in 25%
(219/871). Wound infection was complicated in 42% (364/
871) of ischemic limbs. Aspirin was prescribed in 80% of
patients. Thienopyridines and cilostazol were prescribed in
35% and 51% of patients, respectively. Statins were pre-
scribed in 22% of patients with CLI (data not shown).
Regarding the EVT procedure, direct intervention was per-
formed in 62% of limbs (546/871).
The mean follow up after EVT was 21  19 months. One
year follow up was completed in 826 limbs (94.8%). A
quarter of patients died within 1 year of EVT, and for the 1
year follow up 50% of the initial study population returned
to the outpatient clinic and 20% were interviewed via
phone calls; 5% of patients were lost to follow up.
Prognosis of patients with critical limb ischemia
Survival rate after EVT was 74.7% at 1 year, and 61.7% at 2
years.
Prognosis of critically ischemic limbs after EVT
The rate of freedom from major amputation for limbs in the
Rutherford 5 category was 93% and 91% at 1 and 2 years
after EVT, respectively. Rutherford 6 limbs had a worse
prognosis than Rutherford 5 (1 year freedom from major
amputation: 75%; 2 years: 74%; p < .001; Fig. 1).
Fig. 2 shows the cumulative wound healing rate after EVT
according to limb stratiﬁcation based on Rutherford cate-
gory (Rutherford 5, Rutherford 6 [only heel], Rutherford 6
[not only heel]); 73% of limbs achieved wound healing 1
year after EVT for Rutherford 5. The wound healing rate
after EVT was not signiﬁcantly different between Rutherford
Figure 1. Rate of freedom from major amputation after EVT in Rutherford 5 (n ¼ 585) and 6 (n ¼ 286). Rate of freedom from major
amputation after EVT was signiﬁcantly different between Rutherford 5 and 6 at 24 months (90% vs. 74%; p < 0.05).
Predictors of Delayed Wound Healing after EVT 5696 (only heel) and 5 (60% vs. 73% at 1 year; p ¼ .051). CLI in
Rutherford 6 (not only heel) showed the worst cumulative
healing rate in this setting (49% at 1 year; p < .010 for each
comparison). The median time to wound healing after
revascularization was 96 days for Rutherford 5, and 350
days for Rutherford 6.
The repeat EVT rate was 41.8% at 1 year, and 51.2% at 2
years. The wound healing rate with and without repeat EVT
was not signiﬁcantly different (66.7% vs. 66.1% at 1 year
after EVT; p ¼ .60).Predictors of delayed wound healing after EVT
As shown in Table 3, univariate analysis revealed signiﬁcant
association with delayed wound healing for the following
variables: non-ambulatory status, albumin <3 g/dL, Ruth-
erford 6 (not only heel), wound infection, indirect inter-
vention, one below knee vessel runoff, and zero and one
below ankle vessel runoff. In multivariate analysis, non-
ambulatory status, albumin <3 g/dL, Rutherford 6 (not
only heel), wound infection, indirect intervention, and no
below ankle vessel runoff were independent risk factors of
wound healing after initial EVT.Risk stratiﬁcation for wound healing based on the
multivariable Cox proportional hazard model
Patients were assigned to one of three risk groups based
on number of risk factors (0 or 1 risk factor was deﬁned asa low risk group; 2 or 3 as moderate; and 4, 5, or 6 as
high), with risk factors including non-ambulatory status,
low albumin level, Rutherford 6 (not only heel), wound
infection, indirect EVT, and zero below ankle vessel runoff
(Fig. 3). The cumulative wound healing rate at 12 months
after EVT was as follows: low risk group, 79%; moderate,
62%; and high, 33% (p < .01 for each comparison). Limbs
in the high risk group (number of risk factors ¼ 4, 5, or 6)
had a higher rate of major amputation than those in the
low or moderate risk groups (number of risk factors ¼ 0,
1, 2, or 3) (66.9% and 90.5% at 1 year after EVT; p < .01).
The sensitivity and speciﬁcity for major limb amputation in
the high risk group were calculated to be 32.4% and
89.5%, respectively.
DISCUSSION
Freedom from major amputation 1 year after EVT was
achieved in 88% of patients with CLI secondary to isolated
infrapopliteal lesions. On the other hand, the cumulative
wound healing rate at 1 year after the initial EVT remained
66%. The median wound healing time after EVT was 146
days overall, and 350 days for Rutherford 6. Pre-operative
factors associated with delayed wound healing were non-
ambulatory status, low albumin level, wound extending to
the transmetatarsal level, and wound infection. Angio-
some targeted EVT and number of below ankle runoff
vessels were identiﬁed as procedure independent pre-
dictors for wound healing. Risk stratiﬁcation based on
Figure 2. Cumulative wound healing rate after EVT according to Rutherford category. The rate of wound healing after EVT for Rutherford 5
(black line, n ¼ 585) was not signiﬁcantly different from that for Rutherford 6 (only heel) (78% vs. 69% at 24 months; p ¼ 0.05). Wound
healing rate for Rutherford 6 involving not only heel was signiﬁcantly lower than for Rutherford 6 (heel only) and Rutherford 5 (p < 0.01
for each comparison).
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EVT in patients with ischemic tissue loss.
In this analysis, only technically successful revasculari-
zation cases were enrolled. The rate of EVT failure was
8.5% (81/952). Comparison of intention to treat (i.e.,
including EVT failure cases) and as treated (i.e., excluding
EVT failure cases) data revealed no signiﬁcant difference
between the two groups with respect to major amputa-
tion (85.7% and 87.6% at 1 year after EVT, p ¼ .22), and
wound healing rate (66.7% and 63.7% at 1 year after EVT,
p ¼ .19).
Previous studies have reported time to wound healing
and wound healing rates after revascularization.7e12 After
EVT for CLI with tissue loss, a 54e86% cumulative wound
healing rate at 1 year was achieved (median time to wound
healing: 97e145 days).10e12 The time to wound healing
after bypass surgery (173e186 days) was longer than that
for EVT7e9 because the proportion of Rutherford 6 was
higher in BSX studies than EVT studies. In this study, wound
healing for Rutherford 6 CLI took twice as many days as that
for Rutherford 5.
Serum albumin <3 g/dL was strongly associated with
delayed wound healing in the current study. Azuma et al.9
also reported albumin <3 g/dL as a negative predictor for
wound healing after bypass surgery; however, it is unknownwhether hypoalbuminemia was caused by inﬂammation or
malnutrition.
In previous reports, wound infection was associated with
delayed wound healing.11,19 In this study, the major
amputation rate after EVT was signiﬁcantly different be-
tween wounds with, versus without infection (20% vs. 7%,
respectively); the wound healing rate was also signiﬁcantly
different between the two groups (57% vs. 73%, respec-
tively). Wounds extending to the transmetatarsal level and
complicated by infection demonstrated poor outcomes: 1
year wound healing and amputation rates of 43% and 33%,
respectively (data not shown). Rutherford category 6 with
heel ulcer/gangrene was an independent predictor of
delayed wound healing after BSX. In this study, the impact
of wound location on time to wound healing was examined.
An ischemic wound located at only the heel was deﬁned as
Rutherford 6 in this study. Only heel Rutherford 6 had a
higher wound healing rate than not only heel Rutherford 6.
In a previous report on diabetic ulcers, ulcer location
inﬂuenced ulcer healing,20 with time to wound healing
increasing progressively from toe to mid-foot to heel, which
differs from the ﬁndings in this study. Size and depth of the
wound were not recorded, rendering it difﬁcult to compare
previous reports on diabetic patients with the current
results.
Table 3. Univariate and multivariate analyses: predictors of delayed wound healing after EVT in patients with CLI due to isolated
infrapopliteal lesions.
Factors Univariate analysis Multivariate analysis
HR (95% CI) p HR (95% CI) p
Age  80 years 0.93 (0.75e1.14) 0.519 0.88 (0.71e1.10) 0.282
Male 0.95 (0.79e1.14) 0.630 0.98 (0.79e1.20) 0.855
BMI < 18.5 kg/m2 1.69 (1.35e2.17) 0.778 1.02 (0.80e1.28) 0.863
Non-ambulatory status 1.25 (1.03e1.51) <0.001 1.58 (1.31e1.91) <0.001
Hypertension 1.04 (0.82e1.29) 0.979 0.98 (0.80e1.19) 0.852
Dyslipidemia 1.96 (1.63e2.38) 0.095 0.97 (0.81e1.16) 0.779
Diabetes Mellitus 1.00 (0.83e1.20) 0.359 1.08 (0.87e1.32) 0.460
Regular dialysis 0.86 (0.72e1.02) 0.078 1.11 (0.91e1.34) 0.282
Albumin <3 g/dL 1.09 (0.90e1.33) <0.001 1.42 (1.08e1.86) 0.010
Tissue Loss (versus Rutherford 5) 1.00 (Ref.) 1.00 (Ref.)
Rutherford 6 (only heel) 1.16 (0.98e1.38) 0.051 1.11 (0.79e1.56) 0.538
Rutherford 6 (not only heel) 1.72 (1.33e2.22) <0.001 1.68 (1.33e2.14) <0.001
Wound infection 1.38 (1.00e1.92) <0.001 1.24 (1.03e1.50) 0.021
Indirect intervention 2.22 (1.78e2.77) <0.001 1.28 (1.06e1.55) 0.008
BTK runoff after EVT (versus 3 runoffs) 1.00 (Ref.) 1.00 (Ref.)
2 runoff vessels 1.63 (1.36e1.96) 0.480 0.92 (0.72e1.16) 0.502
1 runoff vessel 1.44 (1.20e1.72) 0.018 1.04 (0.81e1.33) 0.718
BTA runoff after EVT (versus 2 runoffs) 1.00 (Ref) 1.00 (Ref)
1 runoff vessel 1.08 (0.86e1.35) 0.021 1.14 (0.93e1.41) 0.190
0 runoff vessel 1.29 (1.04e1.61) <0.001 1.45 (1.14e1.86) 0.002
BMI ¼ body mass index; EVT ¼ endovascular therapy; BTK ¼ below the knee; BTA ¼ below the ankle; HR ¼ hazard ratio; CI ¼ conﬁdence
interval.
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were previously known independent predictors of delayed
wound healing after revascularization.9,11 From the analysis
of a large number of ischemic limbs, regular dialysis tended
to inﬂuence wound healing (p ¼ .072); however, diabetes
mellitus was not associated with wound prognosis
(p ¼ 0.366).
Regarding elevated CRP level, wound infection was
apparent in 72% of limbs. In a multivariate model including
both wound infection and CRP, they were not independent
predictors for delayed wound healing, presumably because
of multicollinearity; therefore, the presence of both CRP
and wound infection was not inserted in the multivariable
Cox hazard model.
In BSX in Japan, the angiosome concept was not accepted
as an important strategy for ulcer/gangrene healing,9
whereas angiosome targeted EVT has proven useful for
CLI treatment. Although there have been no randomized
controlled trials comparing direct and indirect intervention,
a pooled analysis of nine reports concluded that direct
revascularization of the foot angiosome affected by
ischemic tissue loss may improve wound healing and the
limb salvage rate.21
EVT in below knee lesions is common in CLI management,
and the effectiveness of below ankle intervention has been
reported.22 The impact of the number of BTA runoffs on
wound healing reported recently was conﬁrmed.
Only 22% of patients were prescribed statins. Low BMI
levels (average 22) due to emaciation and malnutrition in
Japanese patients with CLI, and a mean baseline LDL
cholesterol level of 80 mg/dL in this study appear to ac-
count for this relatively low prescription rate.A high restenosis rate in infrapopliteal lesions after EVT
using plain balloon angioplasty has been reported previ-
ously.23 Although infrapopliteal drug coated balloon angio-
plasty appeared to reduce restenosis as compared with
traditional balloon angioplasty in one study with design
limitations,24 in a high quality study, including independent
angiographic and wound core laboratory assessments, a
drug coated balloon did not improve either vessel or limb
prognosis compared with plain balloon angioplasty.25
Further investigation is warranted to determine the popu-
lation of patients who would beneﬁt from intervention with
drug coated balloons.Limitations
This was a sub-analysis of the J-BEAT trial, involving retro-
spective analysis of registry data. Only Japanese CLI pa-
tients, who are characterized by a high proportion of
dialysis dependence, were included in this study. Patients
with CLI who did not receive EVT were not included in this
study; because of the retrospective nature of this study, the
number of CLI patients who underwent primary surgical
bypass could not be accurately determined. Although pre-
dictors for delayed wound healing by multivariate analysis
using pre-procedural (some assessed at procedure time
after choosing intervention modality) and post-procedural
factors were examined, a risk score to predict which CLI
patients would beneﬁt most from EVT versus bypass surgery
remains to be determined.
Heterogeneity in wound management practice among
facilities was also a limitation in this retrospective analysis.
Assessment of the success of EVT by attending physicians
Figure 3. Risk stratiﬁcation by number of risk factors after multivariate analysis. Stratiﬁcation of the patients by number of risk factors
yielded three signiﬁcantly different estimates for wound healing rate at 24 months: 85% for low risk (black line, n ¼ 386), 66% for
moderate risk (red line, n ¼ 371), and 39% for high risk (green line, n ¼ 114) (p < 0.01 for each comparison), respectively.
572 T. Shiraki et al.was not blinded, which might introduce bias. Information
on wound nature (ulcer and gangrene), width and depth, or
on wound brush and pedal arch status after EVT was not
collected. The data in this study were not separated into
training and test sets to develop and to assess, respectively,
the validity of predictive risk stratiﬁcation. The current
ﬁndings therefore should be externally validated in settings
with similar sample characteristics. It remains to be deter-
mined if the developed model can be validated in the
general population sampled independently. Information on
medical therapy used after revascularization was collected
only for antiplatelet and statin medication. Compliance and
discontinuation rates or other details of medication use
during follow up could not be determined.
CONCLUSIONS
The wound healing rate was acceptable after EVT and
similar to those in earlier studies. Non-ambulatory status,
low albumin level, Rutherford 6 (not only heel), wound
infection, indirect intervention, and poor below ankle runoff
were independent predictors for delayed wound healing
after EVT in CLI patients due to infrapopliteal lesions. Risk
stratiﬁcation allows estimation of wound healing rate.
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